Hanna H - Search Results

1

Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.

Raad I, Hachem R, Hanna H, Abi-Said D, Bivins C, Walsh G, Thornby J, Whimbey E, Huaringa A, Sukumaran A. Raad I, et al. Among authors: hanna h. Ann Surg Oncol. 2001 Mar;8(2):179-86. doi: 10.1007/s10434-001-0179-1. Ann Surg Oncol. 2001. PMID: 11258785 Clinical Trial.

2

Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.

Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV. Raad II, et al. Among authors: hanna ha. Cancer. 2003 Sep 1;98(5):1039-47. doi: 10.1002/cncr.11613. Cancer. 2003. PMID: 12942573 Free article. Clinical Trial.

3

Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer.

Husni R, Hachem R, Hanna H, Raad I. Husni R, et al. Among authors: hanna h. Infect Control Hosp Epidemiol. 2002 Feb;23(2):102-3. doi: 10.1086/502016. Infect Control Hosp Epidemiol. 2002. PMID: 11893144

4

Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.

Raad I, Hachem R, Hanna H, Afif C, Escalante C, Kantarjian H, Rolston K. Raad I, et al. Among authors: hanna h. J Antimicrob Chemother. 2004 Apr;53(4):646-9. doi: 10.1093/jac/dkh144. Epub 2004 Mar 3. J Antimicrob Chemother. 2004. PMID: 14998986 Clinical Trial.

5

Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction.

Raad I, Hachem R, Hanna H. Raad I, et al. Among authors: hanna h. J Antimicrob Chemother. 2004 Jun;53(6):1105-8. doi: 10.1093/jac/dkh234. Epub 2004 May 5. J Antimicrob Chemother. 2004. PMID: 15128724 Clinical Trial.

6

Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.

Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I. Ansari SR, et al. Among authors: hanna h. Cancer. 2007 Jun 15;109(12):2615-22. doi: 10.1002/cncr.22705. Cancer. 2007. PMID: 17487860 Free article.

7

Nosocomial Candida guilliermondii fungemia in cancer patients.

Mardani M, Hanna HA, Girgawy E, Raad I. Mardani M, et al. Among authors: hanna ha. Infect Control Hosp Epidemiol. 2000 May;21(5):336-7. doi: 10.1086/501768. Infect Control Hosp Epidemiol. 2000. PMID: 10823569

8

Candida krusei fungemia. An escalating serious infection in immunocompromised patients.

Abbas J, Bodey GP, Hanna HA, Mardani M, Girgawy E, Abi-Said D, Whimbey E, Hachem R, Raad I. Abbas J, et al. Among authors: hanna ha. Arch Intern Med. 2000 Sep 25;160(17):2659-64. doi: 10.1001/archinte.160.17.2659. Arch Intern Med. 2000. PMID: 10999981

9

Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?

Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A, Richardson D, Umphrey JL, Whimbey E, Mansour G. Raad I, et al. Among authors: hanna ha. Infect Control Hosp Epidemiol. 2001 Mar;22(3):136-9. doi: 10.1086/501879. Infect Control Hosp Epidemiol. 2001. PMID: 11310690 Clinical Trial.

10

Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients.

Hanna HA, Raad I. Hanna HA, et al. Infect Control Hosp Epidemiol. 2001 Mar;22(3):165-6. doi: 10.1086/501885. Infect Control Hosp Epidemiol. 2001. PMID: 11310696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters